Added to YB: 2025-09-25
Pitch date: 2025-09-23
GBT.PA [neutral]
Guerbet SA
-33.38%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide.
Market Cap
EUR 139.5M
Pitch Price
EUR 14.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.97
P/E
-1.29
EV/Sales
0.57
Sector
Health Care Equipment and Supplies
Category
turnaround
Guerbet (GBT France): leadership change signals a reset after profit warning
GBT.PA (quick overview): French contrast agent leader in reset mode after profit warning & CEO change. CFO Jérôme Estampes interim CEO as board seeks permanent replacement. Core challenges: weak France trends, US distributor mix, operational setbacks. Dotarem/Elucirem products face regulatory pressure & competition. Transformation needed across industrial/commercial infrastructure. Leadership change potential catalyst but timing uncertain.
Read full article (1 min)